RCAG
DPLO

Rehmann Capital Advisory Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Rehmann Capital Advisory Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-235
Closed -$4.56K – 2214
2018
Q3 		$4.56K Sell
235
-68
-22% -$1.45K ﹤0.01% 1578
2018
Q2 		$7.75K Sell
303
-2,033
-87% -$47.4K ﹤0.01% 1429
2018
Q1 		$47K Buy
+2,336
New +$54.5K 0.01% 791

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rehmann Capital Advisory Group's DPLO Position: Q4 2018 in Review

Rehmann Capital Advisory Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2018, closing a stake of 235 shares — an estimated $4.56K sold.

Rehmann Capital Advisory Group first reported a position in DPLO in Q1 2018 and held it in 3 quarters. The position peaked at $47K in Q1 2018. 157 funds tracked by Wall St. Rank hold DPLO as of Q4 2018.

  • Rehmann Capital Advisory Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2018 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 235 DIPLOMAT PHARMACY, INC. shares in Q4 2018, an estimated $4.56K.
  • Rehmann Capital Advisory Group first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2018 and held it in 3 quarters.
  • Rehmann Capital Advisory Group's DIPLOMAT PHARMACY, INC. position peaked at $47K in Q1 2018.
  • 157 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2018.

Based on Rehmann Capital Advisory Group's 13F filing for Q4 2018, filed 12 Feb 2019.